Showing results (241-250 of 372) with videos related to
Sort By:
Pageof 38
JAMA|February 5, 1998
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart diseaseS P Roose, F Laghrissi-Thode, J S Kennedy, et al.Journal of the Peripheral Nervous System : JPNS|May 11, 2023
Validation of the parent-proxy version of the pediatric Charcot-Marie-Tooth disease quality of life instrument for children aged 0-7 yearsTong Tong Wu, Richard S Finkel, Carly E Siskind, et al.Molecular Genetics and Metabolism|November 20, 2012
Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidaseTyler Mark Pierson, Paola A Torres, Bei-Jin Zeng, et al.Emerging Infectious Diseases|July 27, 2002
Outbreak of cyclosporiasis associated with imported raspberries, Philadelphia, Pennsylvania, 2000Alice Y Ho, Adriana S Lopez, Michael G Eberhart, et al.Muscle & Nerve|July 30, 2013
The motor neuron response to SMN1 deficiency in spinal muscular atrophyPeter B Kang, Clifton L Gooch, Michael P McDermott, et al.Annals of Clinical and Translational Neurology|May 14, 2022
Scientific rationale for a higher dose of nusinersenRichard S Finkel, Monique M Ryan, Samuel Ignacio Pascual Pascual, et al.Annals of Neurology|April 24, 2012
Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disabilityJoshua Burns, Robert Ouvrier, Tim Estilow, et al.Orphanet Journal of Rare Diseases|April 7, 2020
Longitudinal natural history of type I spinal muscular atrophy: a critical reviewEugenio Mercuri, Simona Lucibello, Marco Perulli, et al.Lancet (London, England)|April 25, 2015
Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trialGunnar M Buyse, Thomas Voit, Ulrike Schara, et al.Plos Pathogens|February 24, 2012
Portrait of Candida albicans adherence regulatorsJonathan S Finkel, Wenjie Xu, David Huang, et al.Pageof 38